All Posts

UFH Woolley2

Nov. 16: Research!America Town Hall

Published: November 9th, 2018

UFH lo

Vets Day

Number of veterans with Alzheimer’s and other dementias on the rise

Published: November 9th, 2018

Retired Col.​ Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.

R25 1

UF neurosurgery and neurology departments team up for interdisciplinary NIH grant

Published: November 7th, 2018

Five-year National Institutes of Health Research Education Program, or R25, grant supports residents’ research education activities and academic career development.

Hunt2

Drug addiction takes toll mentally, physically

Published: November 6th, 2018

Jason Hunt, M.D., assistant professor of addiction medicine, was featured as an expert source in a Citrus County Chronicle article about opioid addiction.

Chronic

Genes may affect the severity of CTE

Published: November 4th, 2018

Michael Jaffee, M.D., vice chair and associate professor of neurology and director of the Trauma, Concussion and Sports Neuromedicine Program, commented about a new CTE study in The Boston Globe.

CARE2

World’s most comprehensive concussion study expanded

Published: October 31st, 2018

UF among 30 colleges and military service academies involved with NCAA and Department of Defense concussion study.

NCAA and Department of Defense expand concussion study with $22.5 million in new funding

Published: October 31st, 2018

Athletes at the University of Florida to continue participation.

MBI night mobile

Oct. 30: Neurosurgery Town Hall Meeting

Published: October 25th, 2018

MBRF

Nov. 4: The Evelyn F. McKnight Brain Research Foundation Poster Reception

Published: October 25th, 2018

View the program and poster summaries of the upcoming MBRF Poster Reception.

Deleyrolle 1

Study shows how fat fuels cells in brain tumors

Published: October 23rd, 2018

A new study led by Loic Deleyrolle, Ph.D., an assistant professor of neurosurgery, has implications for advancing new metabolic therapies for glioblastoma, the deadliest form of brain cancer.